Showing results (551-560 of 619) with videos related to

Sort By:
Pageof 62
Arthritis & Rheumatology (Hoboken, N.J.)|May 1, 2014
Halofuginone ameliorates autoimmune arthritis in mice by regulating the balance between Th17 and Treg cells and inhibiting osteoclastogenesisMi-Kyung Park, Jin-Sil Park, Eun-Mi Park, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2006
Identification and characterization of amino-piperidinequinolones and quinazolinones as MCHr1 antagonistsChristopher Blackburn, Matthew J LaMarche, James Brown, et al.
Blood|October 21, 2011
The ability of MLL to bind RUNX1 and methylate H3K4 at PU.1 regulatory regions is impaired by MDS/AML-associated RUNX1/AML1 mutationsGang Huang, Xinghui Zhao, Lan Wang, et al.
Ebiomedicine|March 26, 2025
Cerebrospinal fluid metabolomics in autistic regression reveals dysregulation of sphingolipids and decreased β-hydroxybutyrateJingya Yan, Velda X Han, Hannah F Jones, et al.
Aging and Disease|February 5, 2025
Advancing Hydrocephalus Management: Pathogenesis Insights, Therapeutic Innovations, and Emerging ChallengesXiuyun Liu, Hui Zhi, Marek Czosnyka, et al.
Stroke|January 29, 2026
Dissecting Aneurysm in Cervical Artery Dissection: Insights from the STOP-CAD StudyMuhib Khan, Zafer Keser, Liqi Shu, et al.
Bioorganic & Medicinal Chemistry Letters|June 14, 2005
Identification of aminopiperidine benzamides as MCHr1 antagonistsAnil Vasudevan, Mary K Verzal, Derek Wodka, et al.
Minerva Urology and Nephrology|June 22, 2021
Risk factors for progression of chronic kidney disease after robotic partial nephrectomy in elderly patients: results from a multi-institutional collaborative seriesUmberto Anceschi, Aldo Brassetti, Gabriele Tuderti, et al.
Hospital Pediatrics|February 5, 2024
Performance of Febrile Infant Decision Tools on Hypothermic Infants Evaluated for InfectionKathryn Westphal, Hania Adib, Vignesh Doraiswamy, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 28, 2024
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trialYoon-Koo Kang, Min-Hee Ryu, Maria Di Bartolomeo, et al.
Pageof 62